These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18991394)

  • 1. NMR studies of a heterotypic Sam-Sam domain association: the interaction between the lipid phosphatase Ship2 and the EphA2 receptor.
    Leone M; Cellitti J; Pellecchia M
    Biochemistry; 2008 Dec; 47(48):12721-8. PubMed ID: 18991394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sam domain of the lipid phosphatase Ship2 adopts a common model to interact with Arap3-Sam and EphA2-Sam.
    Leone M; Cellitti J; Pellecchia M
    BMC Struct Biol; 2009 Sep; 9():59. PubMed ID: 19765305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.
    Mercurio FA; Di Natale C; Pirone L; Iannitti R; Marasco D; Pedone EM; Palumbo R; Leone M
    Sci Rep; 2017 Dec; 7(1):17474. PubMed ID: 29234063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sam domain-based stapled peptides: Structural analysis and interaction studies with the Sam domains from the EphA2 receptor and the lipid phosphatase Ship2.
    Mercurio FA; Pirone L; Di Natale C; Marasco D; Pedone EM; Leone M
    Bioorg Chem; 2018 Oct; 80():602-610. PubMed ID: 30036816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD and NMR conformational studies of a peptide encompassing the Mid Loop interface of Ship2-Sam.
    Mercurio FA; Scognamiglio PL; Di Natale C; Marasco D; Pellecchia M; Leone M
    Biopolymers; 2014 Nov; 101(11):1088-98. PubMed ID: 24889333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation.
    Zhuang G; Hunter S; Hwang Y; Chen J
    J Biol Chem; 2007 Jan; 282(4):2683-94. PubMed ID: 17135240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural investigation of a C-terminal EphA2 receptor mutant: Does mutation affect the structure and interaction properties of the Sam domain?
    Mercurio FA; Costantini S; Di Natale C; Pirone L; Guariniello S; Scognamiglio PL; Marasco D; Pedone EM; Leone M
    Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1095-1104. PubMed ID: 28602916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the first Sam domain of Odin and binding studies with the EphA2 receptor.
    Mercurio FA; Marasco D; Pirone L; Pedone EM; Pellecchia M; Leone M
    Biochemistry; 2012 Mar; 51(10):2136-45. PubMed ID: 22332920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring a Potential Optimization Route for Peptide Ligands of the Sam Domain from the Lipid Phosphatase Ship2.
    Vincenzi M; Mercurio FA; La Manna S; Palumbo R; Pirone L; Marasco D; Pedone EM; Leone M
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39408946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR structure of a heterodimeric SAM:SAM complex: characterization and manipulation of EphA2 binding reveal new cellular functions of SHIP2.
    Lee HJ; Hota PK; Chugha P; Guo H; Miao H; Zhang L; Kim SJ; Stetzik L; Wang BC; Buck M
    Structure; 2012 Jan; 20(1):41-55. PubMed ID: 22244754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the EphA2-Sam/Ship2-Sam Association through Peptide Ligands: Studying the Combined Effect of Charge and Aromatic Character.
    Vincenzi M; Mercurio FA; Palumbo R; La Manna S; Pirone L; Marasco D; Pedone EM; Leone M
    J Med Chem; 2024 Sep; 67(18):16649-16663. PubMed ID: 39259672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Related Mutations in the Sam Domains of EphA2 Receptor and Ship2 Lipid Phosphatase: A Computational Study.
    Vincenzi M; Mercurio FA; Autiero I; Leone M
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and analysis of EphA2-SAM peptide ligands: A multi-disciplinary screening approach.
    Mercurio FA; Di Natale C; Pirone L; Marasco D; Calce E; Vincenzi M; Pedone EM; De Luca S; Leone M
    Bioorg Chem; 2019 Mar; 84():434-443. PubMed ID: 30576907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hunting for Novel Routes in Anticancer Drug Discovery: Peptides against Sam-Sam Interactions.
    Mercurio FA; Vincenzi M; Leone M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?
    Mercurio FA; Leone M
    Curr Med Chem; 2016; 23(42):4718-4734. PubMed ID: 27804871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting EphA2-Sam and Its Interactome: Design and Evaluation of Helical Peptides Enriched in Charged Residues.
    Mercurio FA; Marasco D; Di Natale C; Pirone L; Costantini S; Pedone EM; Leone M
    Chembiochem; 2016 Nov; 17(22):2179-2188. PubMed ID: 27763725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Ship2-Sam with peptide ligands: Novel insights from a multidisciplinary approach.
    Vincenzi M; Anna Mercurio F; Di Natale C; Palumbo R; Pirone L; La Manna S; Marasco D; Maria Pedone E; Leone M
    Bioorg Chem; 2022 May; 122():105680. PubMed ID: 35248981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterotypic Sam-Sam association between Odin-Sam1 and Arap3-Sam: binding affinity and structural insights.
    Mercurio FA; Marasco D; Pirone L; Scognamiglio PL; Pedone EM; Pellecchia M; Leone M
    Chembiochem; 2013 Jan; 14(1):100-6. PubMed ID: 23239578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide Fragments of Odin-Sam1: Conformational Analysis and Interaction Studies with EphA2-Sam.
    Mercurio FA; Di Natale C; Pirone L; Scognamiglio PL; Marasco D; Pedone EM; Saviano M; Leone M
    Chembiochem; 2015 Jul; 16(11):1629-36. PubMed ID: 26120079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions.
    Wang Y; Shang Y; Li J; Chen W; Li G; Wan J; Liu W; Zhang M
    Elife; 2018 May; 7():. PubMed ID: 29749928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.